HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability.

AbstractBACKGROUND:
Patients with heart disease are at risk of developing congestive heart failure (CHF). Neurohormonal activation may make an important contribution.
AIM:
In stable heart patients from primary care, to examine neuroendocrine markers of cardiac performance for the association to cardiac dysfunction, morbidity and mortality.
METHODS:
Plasma N-terminal atrial natriuretic peptide (N-ANP), catecholamines, 24-h ECG and blood pressure, serum urea and creatinine, echocardiography, chest X-ray and physical examination were performed. Death was recorded during 5 to 7 years of follow-up.
RESULTS:
The study included 56 patients. Mean age was 71 years, 54% were men, 43% had clinical signs of CHF, 39 + 52 + 9% were in NYHA I + II + III, 34% had echocardiographic cardiac dysfunction, and 18 died during follow-up. N-ANP was related to all subtypes of cardiac dysfunction (p < 0.05). Catecholamines and premature ventricular captures (PVC) were related to valvular and systolic dysfunction, but heart rate variability and dipping blood pressure were not (p > 0.05). On multivariate analyses only, N-ANP and PVC were associated with clinical signs of CHF, echocardiographic cardiac dysfunction, and mortality (p < 0.05).
CONCLUSIONS:
Plasma N-ANP was stronger than catecholamines and variables of 24-h monitoring (blood pressure and electrocardiogram) in predicting morbidity and mortality, thereby supporting the use of cardiac natriuretic peptides (i.e. N-ANP, BNP, or N-BNP) as the most valuable biomarker in community patients at risk of CHF.
AuthorsO W Nielsen, V Rasmussen, N J Christensen, J F Hansen
JournalScandinavian journal of clinical and laboratory investigation (Scand J Clin Lab Invest) Vol. 64 Issue 7 Pg. 619-28 ( 2004) ISSN: 0036-5513 [Print] England
PMID15513318 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • N-terminal proatrial natriuretic peptide
  • Protein Precursors
  • Atrial Natriuretic Factor
  • Norepinephrine
  • Epinephrine
Topics
  • Adult
  • Aged
  • Atrial Natriuretic Factor (blood)
  • Community Health Services
  • Epinephrine (blood)
  • Female
  • Heart Diseases (diagnosis, epidemiology, mortality)
  • Heart Failure (diagnosis)
  • Heart Rate (physiology)
  • Humans
  • Male
  • Middle Aged
  • Morbidity
  • Norepinephrine (blood)
  • Prognosis
  • Protein Precursors (blood)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: